37 | Temozolomide (Temodar)FDA LinkGeneric
03/2024
-
03/2005 |
18 | Lomustine (CCNU)FDA Link
01/2023
-
06/2006 |
12 | Procarbazine (Matulane)FDA Link
10/2022
-
06/2006 |
12 | Vincristine (Oncovin)FDA LinkGeneric
10/2022
-
06/2006 |
8 | Bevacizumab (Avastin)FDA Link
01/2023
-
03/2016 |
6 | DNA (Deoxyribonucleic Acid)IBA
01/2019
-
07/2011 |
6 | MethyltransferasesIBA
01/2019
-
10/2008 |
5 | Biomarkers (Surrogate Marker)IBA
11/2020
-
08/2008 |
4 | epidermal growth factor receptor VIIIIBA
12/2022
-
03/2009 |
4 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022
-
07/2011 |
4 | depatuxizumab mafodotinIBA
08/2021
-
01/2020 |
4 | ErbB Receptors (EGF Receptor)IBA
01/2020
-
06/2008 |
4 | CilengitideIBA
05/2018
-
09/2014 |
4 | Fluorouracil (Carac)FDA LinkGeneric
06/2009
-
08/2006 |
3 | Anticonvulsants (Antiepileptic Drugs)IBA
01/2023
-
03/2016 |
3 | Immunoconjugates (Immunoconjugate)IBA
01/2021
-
01/2020 |
3 | O-(6)-methylguanineIBA
01/2019
-
03/2016 |
3 | IntegrinsIBA
05/2018
-
09/2014 |
2 | SteamIBA
04/2024
-
12/2023 |
2 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
04/2024
-
12/2023 |
2 | RNA (Ribonucleic Acid)IBA
03/2024
-
10/2023 |
2 | Proteins (Proteins, Gene)FDA Link
12/2023
-
10/2008 |
2 | Alkylating AgentsIBA
12/2023
-
03/2005 |
2 | Levetiracetam (Keppra)FDA LinkGeneric
01/2022
-
03/2016 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
-
01/2010 |
2 | Leucovorin (Folinic Acid)FDA Link
06/2009
-
08/2006 |
2 | Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2009
-
08/2006 |
2 | Carmustine (FIVB)FDA Link
03/2009
-
06/2008 |
2 | Cisplatin (Platino)FDA LinkGeneric
10/2007
-
01/2002 |
1 | Proteasome Endopeptidase Complex (Proteasome)IBA
03/2024 |
1 | marizomibIBA
03/2024 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2023 |
1 | Antidepressive Agents (Antidepressants)IBA
01/2023 |
1 | Cyclin-Dependent Kinase 4IBA
01/2023 |
1 | TrabectedinIBA
01/2022 |
1 | Angiogenesis InhibitorsIBA
01/2022 |
1 | GadoliniumIBA
12/2021 |
1 | Contrast MediaIBA
12/2021 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2020 |
1 | Telomerase (Telomerase Reverse Transcriptase)IBA
11/2020 |
1 | Oxygen (Dioxygen)IBA
10/2020 |
1 | Metformin (Glucophage)FDA LinkGeneric
01/2020 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2020 |
1 | LigandsIBA
01/2020 |
1 | Tyrosine Kinase InhibitorsIBA
01/2020 |
1 | monomethylauristatin FIBA
01/2020 |
1 | NucleotidesIBA
01/2020 |
1 | EpitopesIBA
01/2020 |
1 | Indicators and Reagents (Reagents)IBA
01/2019 |
1 | Angiotensin II Type 1 Receptor BlockersIBA
05/2018 |
1 | Angiotensin Receptor AntagonistsIBA
05/2018 |
1 | Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2018 |
1 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2018 |
1 | vasectrin IIIIBA
01/2018 |
1 | AnticoagulantsIBA
01/2018 |
1 | temsirolimusFDA Link
10/2016 |
1 | Transforming Growth Factors (Transforming Growth Factor)IBA
03/2016 |
1 | Valproic Acid (Depakote)FDA LinkGeneric
03/2016 |
1 | SteroidsIBA
01/2016 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 |